Advertise here
Advertise here

US approves first nasal spray for anaphylaxis

The FDA has approved Neffy, the first adrenaline nasal spray for treating allergic reactions in adults and children over 30 kg. It is a single dose administered into one nostril. Neffy offers a non-invasive alternative to traditional adrenaline injections for emergency situations, including life-threatening reactions.

Source link

Advertise here
error: Content is protected !!